Dihydromyricetin, a natural product derived from ampelopsis grossedentata, exhibits profound antitumor activity against NSCLC cells by downregulating the epidermal growth factor receptor (EGFR)/Akt/survivin signal pathway 61. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.